Good news on the pancreatic cancer front has been slow for some time now. But the situation may have changed, as a new study suggests that a combination of two medications may improve the outlook for patients whose pancreatic cancer has spread.

Gemzar (gemcitabine) is the standard of care for pancreatic cancer. Results from a trial showed that adding another medication worked even better.

Currently, there's only one chemotherapy agent being used to treat pancreatic cancer. Gemzar (gemcitabine) works for some patients, but not others.